The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Initial Response To Percutaneous Ablation Predicts Survival in Patients With Hepatocellular Carcinoma
Open accessAbstract
Outcome predictors in patients with hepatocellular carcinoma (HCC) who are treated with percutaneous ablation are ill defined, and it is unknown if successful therapy is associated with improved survival. In our study, 282 cirrhotic patients with early nonsurgical HCC were treated with percutaneous ablation during a 15–year period. Single tumors were seen in 244 patients, and 2 to 3 nodules were seen in 38 patients. Initial complete response was achieved in 192 patients and was independently related to the size of the main tumor ( P = .015) and tumor stage ( P = .0001) (≤2 cm, 96%; 2.1–3 cm, 78%; >3 cm, 56%; 2–3 nodules, 46%). At the end of follow–up, 80 patients presented sustained complete response. The 1–, 3–, and 5–year survival rates were 87%, 51%, and 27%, respectively. The independent predictors of survival were Child–Turcotte–Pugh class ( P = .0001) and initial complete response ( P = .006). Child–Turcotte–Pugh class A patients with initial complete response achieved 42% survival at 5 years; this figure increased to 63% in patients with tumors 2 cm or smaller. In conclusion , our results demonstrate that initial complete response to percutaneous ablation is associated with an improved survival in both Child–Turcotte–Pugh class A and B patients with nonsurgical HCC. Accordingly, initial complete tumor necrosis should be considered a relevant therapeutic target irrespective of tumor size and liver function. (Hepatology 2004;40:1352-1360.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Self-citationEstimating the world cancer burden: Globocan 2000
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.1440 · Cited by 3,721
Llovet, J. M., Burroughs, A., & Bruix, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14964-1 · Cited by 3,608
Self-citationLlovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029
Self-citationLlovet, J. M., Fuster, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510300629 · Cited by 1,708
Self-citationSmall Hepatocellular Carcinoma: Treatment with Radio-frequency Ablation versus Ethanol Injection
Livraghi, T., Goldberg, S. N., Lazzaroni, S., Meloni, F., Solbiati, L., & Gazelle, G. S. (1999) · Radiology · doi:10.1148/radiology.210.3.r99fe40655 · Cited by 1,283
Prognostic prediction and treatment strategy in hepatocellular carcinoma
Bruix, J., & Llovet, J. M. (2002) · Hepatology · doi:10.1053/jhep.2002.32089 · Cited by 1,099
Self-citationLencioni, R. A., Allgaier, H.-P., Cioni, D., Olschewski, M., Deibert, P., Crocetti, L., Frings, H., Laubenberger, J., Zuber, I., Blum, H. E., et al. (2003) · Radiology · doi:10.1148/radiol.2281020718 · Cited by 998
Livraghi, T., Giorgio, A., Marin, G., Salmi, A., de Sio, I., Bolondi, L., Pompili, M., Brunello, F., Lazzaroni, S., & Torzilli, G. (1995) · Radiology · doi:10.1148/radiology.197.1.7568806 · Cited by 939
Bruix, J., Castells, A., Bosch, J., Feu, F., Fuster, J., Garcia-Pagan, J., Visa, J., Bru, C., & Rodes, J. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70070-7 · Cited by 895
Self-citationTakayama, T., Sekine, T., Makuuchi, M., Yamasaki, S., Kosuge, T., Yamamoto, J., Shimada, K., Sakamoto, M., Hirohashi, S., Ohashi, Y., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02654-4 · Cited by 847
An Analysis of 412 Cases of Hepatocellular Carcinoma at a Western Center
Fong, Y., Sun, R. L., Jarnagin, W., & Blumgart, L. H. (1999) · Annals of Surgery · doi:10.1097/00000658-199906000-00005 · Cited by 796
Llovet, J. M., Vilana, R., Brú, C., Bianchi, L., Salmeron, J. M., Boix, L., Ganau, S., Sala, M., Pagès, M., Ayuso, C., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.24233 · Cited by 759
Self-citationArii, S., Yamaoka, Y., Futagawa, S., Inoue, K., Kobayashi, K., Kojiro, M., Makuuchi, M., Nakamura, Y., Okita, K., & Yamada, R. (2000) · Hepatology · doi:10.1053/jhep.2000.20456 · Cited by 725
Focus on hepatocellular carcinoma
Bruix, J., Boix, L., Sala, M., & Llovet, J. M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00058-3 · Cited by 570
Self-citationBruix, J., Llovet, J. M., Castells, A., Montañá, X., Brú, C., Ayuso, M. D. C., Vilana, R., & Rodés, J. (1998) · Hepatology · doi:10.1002/hep.510270617 · Cited by 533
Self-citationIizuka, N., Oka, M., Yamada-Okabe, H., Nishida, M., Maeda, Y., Mori, N., Takao, T., Tamesa, T., Tangoku, A., Tabuchi, H., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12775-4 · Cited by 511
Nagasue, N., Uchida, M., Makino, Y., Takemoto, Y., Yamanoi, A., Hayashi, T., Chang, Y., Kohno, H., Nakamura, T., & YUKAYA, H. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90724-q · Cited by 396
Image-guided Tumor Ablation: Proposal for Standardization of Terms and Reporting Criteria
Goldberg, S. N., Charboneau, J. W., Dodd, G. D., Dupuy, D. E., Gervais, D. A., Gillams, A. R., Kane, R. A., Lee, F. T., Livraghi, T., McGahan, J. P., et al. (2003) · Radiology · doi:10.1148/radiol.2282021787 · Cited by 375
Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection
Izumi, R., Shimizu, K., II, T., Yagi, M., Matsui, O., Nonomura, A., & Miyazaki, I. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90707-2 · Cited by 371
Sala, M., Fuster, J., Llovet, J. M., Navasa, M., Solé, M., Varela, M., Pons, F., Rimola, A., García-Valdecasas, J. C., Brú, C., et al. (2004) · Liver Transplantation · doi:10.1002/lt.20202 · Cited by 297
Self-citationVilana, R., Bruix, J., Bru, C., Ayuso, C., Solé, M., & Rodés, J. (1992) · Hepatology · doi:10.1002/hep.1840160212 · Cited by 270
Self-citationPredictive factors for postoperative recurrence of hepatocellular carcinoma
Okada, S., Shimada, K., Yamamoto, J., Takayama, T., Kosuge, T., Yamasaki, S., Sakamoto, M., & Hirohashi, S. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90419-7 · Cited by 268
Yamamoto, J., Okada, S., Shimada, K., Okusaka, T., Yamasaki, S., Ueno, H., & Kosuge, T. (2001) · Hepatology · doi:10.1053/jhep.2001.27950 · Cited by 215
Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection
Ishii, H., Okada, S., Nose, H., Okusaka, T., Yoshimori, M., Takayama, T., Kosuge, T., Yamasaki, S., Sakamoto, M., & Hirohashi, S. (1996) · Cancer · Cited by 184
Focus on dysplastic nodules and early hepatocellular carcinoma: An Eastern point of view
Kojiro, M. (2004) · Liver Transplantation · doi:10.1002/lt.20042 · Cited by 171
Khan, K. N., Yatsuhashi, H., Yamasaki, K., Yamasaki, M., Inoue, O., Koga, M., & Yano, M. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80072-0 · Cited by 162
Castellano, L., Calandra, M., Blanco, C. D. V., et al. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80324-8 · Cited by 91
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Self-citationLlovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Self-citationManagement of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Self-citationEASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539
Metadata
- Authors
- Sala, M., Llovet, J. M., Vilana, R., Bianchi, L., Solé, M., Ayuso, C., Brú, C., & Bruix, J.
- Venue
- Hepatology
- Published
- 2004-12
- Volume
- 40
- Issue
- 6
- Pages
- 1352-1360
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2000681830
- Cited by
- 447
- References
- 28
- FWCI
- 13.59
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.